Recorded Presentations from the NCCN 2019 Annual Congress: Hematologic Malignancies™
Although advances in treatment options for patients with hematologic malignancies are encouraging, the rapidly changing scientific and clinical environment represents a daunting challenge for practitioners.
Category
Format
  • Enduring Activity
  • Recorded Webcast
Credits
New Therapies for Ovarian Cancer
This information was originally presented at the NCCN 2019 Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, March 21-23, 2019.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Kidney Cancer, Version 2.2020
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non–clear cell renal cell carcinoma, and are intended to assist with clinical decision-making.
Category
  • Kidney Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Endometrial Cancer
Minimally invasive surgical techniques for endometrial cancers, particularly robotic-assisted laparoscopy, have been shown to decrease surgical morbidity and improve 30-day postoperative outcomes for appropriately selected patients with endometrial cancer. Despite evidence of improved outcomes, disparities persist in awareness of and access to minimally invasive surgery.
Category
  • Women's Health Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentation from the NCCN Oncology Case Manager and Medical Director Program: Updates in the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphomas
Case managers and medical directors are challenged to maintain a high awareness of the recent therapeutic advances in the management of FL and DLBCL in order to develop an efficient coordinated treatment approach that incorporates novel therapies in the appropriate patient population.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentations from the NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™
The management of cancer is constantly evolving through the introduction of new developments related to cancer treatment and supportive care. This program will provide hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.
Category
  • Hematologic Malignancies
Format
  • Enduring Activity
Credits
Prevention of Infection in Patients with Hematologic Malignancies
Nurse practitioners and other health care providers play a critical role in the recognition and management of cancer-related infections.
Category
  • Hematologic Malignancies
Format
  • Enduring Activity
Credits
  • ANCC contact hours
  • Participation
  • Nurse
Management of Bone Health in Patients with Multiple Myeloma
With improvement in treatment options and supportive care, patients with MM are living longer. The majority of patients with MM are at risk for both osteolytic bone lesions and osteoporosis.
Category
  • Multiple Myeloma
Format
  • Enduring Activity
Credits
  • ANCC contact hours
  • Participation
  • Nurse
Updates in the Management of Tumor Lysis Syndrome
TLS is a potentially serious complication of anticancer therapy. If left untreated, its progression may cause acute kidney failure, cardiac arrhythmias, seizures, loss of muscle control, and death.
Category
  • Hematologic Malignancies
Format
  • Enduring Activity
Credits
  • ANCC contact hours
  • Participation
  • Nurse
Management of Toxicities Related to CAR T-Cell Therapy
CAR T-cell therapy is associated with a novel toxicity profile with complex monitoring and supportive care requirements.
Category
  • Hematologic Malignancies
Format
  • Enduring Activity
Credits
  • ANCC contact hours
  • Participation
  • Nurse

Pages